These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 15704144)

  • 1. Beta-endorphin decreases fatigue and increases glucose uptake independently in normal and dystrophic mice.
    Khan S; Evans AA; Hughes S; Smith ME
    Muscle Nerve; 2005 Apr; 31(4):481-6. PubMed ID: 15704144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of beta-endorphin on the contractile responses in mouse skeletal muscle.
    Khan S; Smith ME
    Muscle Nerve; 1995 Nov; 18(11):1250-6. PubMed ID: 7565921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for a hormonal action of beta-endorphin to increase glucose uptake in resting and contracting skeletal muscle.
    Evans AA; Khan S; Smith ME
    J Endocrinol; 1997 Nov; 155(2):387-92. PubMed ID: 9415073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delta opioid receptors mediate glucose uptake in skeletal muscles of lean and obese-diabetic (ob/ob) mice.
    Evans AA; Tunnicliffe G; Knights P; Bailey CJ; Smith ME
    Metabolism; 2001 Dec; 50(12):1402-8. PubMed ID: 11735084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Administration of insulin-like growth factor-I improves fatigue resistance of skeletal muscles from dystrophic mdx mice.
    Gregorevic P; Plant DR; Lynch GS
    Muscle Nerve; 2004 Sep; 30(3):295-304. PubMed ID: 15318340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of dy/dy dystrophic diaphragm by 3,4-diaminopyridine.
    van Lunteren E; Moyer M
    Muscle Nerve; 2002 Jul; 26(1):71-8. PubMed ID: 12115951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-like growth factor-I analogue protects muscles of dystrophic mdx mice from contraction-mediated damage.
    Gehrig SM; Ryall JG; Schertzer JD; Lynch GS
    Exp Physiol; 2008 Nov; 93(11):1190-8. PubMed ID: 18567600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of beta-endorphin C-terminal peptides on glucose uptake in isolated skeletal muscles of the mouse.
    Evans A; Smith ME
    Peptides; 1997; 18(1):165-7. PubMed ID: 9114466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isotonic fatigue in laminin alpha2-deficient dy/dy dystrophic mouse diaphragm.
    Pollarine J; Moyer M; Van Lunteren E
    Muscle Nerve; 2007 Nov; 36(5):672-8. PubMed ID: 17661374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of beta-endorphin and alpha-melanotropin on muscle wasting in mice.
    Smith ME; Hughes S
    J Neurol Sci; 1995 May; 129 Suppl():127-30. PubMed ID: 7595603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic administration of IGF-I enhances oxidative status and reduces contraction-induced injury in skeletal muscles of mdx dystrophic mice.
    Schertzer JD; Ryall JG; Lynch GS
    Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E499-505. PubMed ID: 16621899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear factor kappa-B blockade reduces skeletal muscle degeneration and enhances muscle function in Mdx mice.
    Messina S; Bitto A; Aguennouz M; Minutoli L; Monici MC; Altavilla D; Squadrito F; Vita G
    Exp Neurol; 2006 Mar; 198(1):234-41. PubMed ID: 16410003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of gender and prior swim exercise on glucose uptake in isolated skeletal muscles from mice.
    Kim J; Arias EB; Cartee GD
    J Physiol Sci; 2006 Aug; 56(4):305-12. PubMed ID: 16934174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study of membrane proteins in skeletal muscle of normal or dystrophic mice. Effects of isaxonine phosphate (author's transl)].
    Lucas-Heron B; Guiheneuc P
    Nouv Presse Med; 1982 Apr; 11(16):1250-3. PubMed ID: 6896574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of Ca2+ influx for insulin-mediated glucose uptake in skeletal muscle.
    Lanner JT; Katz A; Tavi P; Sandström ME; Zhang SJ; Wretman C; James S; Fauconnier J; Lännergren J; Bruton JD; Westerblad H
    Diabetes; 2006 Jul; 55(7):2077-83. PubMed ID: 16804078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consequences of thyroxine treatment on diaphragm and EDL of normal and dystrophic hamsters.
    Singh YN; Schlenker EH; Singh BN; Burbach JA
    Can J Physiol Pharmacol; 2004 May; 82(5):345-52. PubMed ID: 15213735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of nerve section on beta-endorphin and alpha-melanotropin immunoreactivity in motor nerves of normal and dystrophic mice.
    Hughes S; Smith ME
    Neurosci Lett; 1988 Sep; 92(1):1-7. PubMed ID: 2847088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pentoxifylline fails to attenuate fibrosis in dystrophic (mdx) diaphragm muscle.
    Gosselin LE; Williams JE
    Muscle Nerve; 2006 Jun; 33(6):820-3. PubMed ID: 16502423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Actions of beta-endorphin peptides on the contractions of mouse diaphragm muscle.
    Khan S; Smith ME
    Peptides; 1997; 18(1):87-92. PubMed ID: 9114457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First evaluation of the potential effectiveness in muscular dystrophy of a novel chimeric compound, BN 82270, acting as calpain-inhibitor and anti-oxidant.
    Burdi R; Didonna MP; Pignol B; Nico B; Mangieri D; Rolland JF; Camerino C; Zallone A; Ferro P; Andreetta F; Confalonieri P; De Luca A
    Neuromuscul Disord; 2006 Apr; 16(4):237-48. PubMed ID: 16542837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.